Alpha 2.0
Login Register
» Authors » Nabiel Mikhail

Nabiel Mikhail

Explore the profile of Nabiel Mikhail including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 535
Followers 0
Related Specialties
Gastroenterology
Tropical Medicine
Public Health
Top 10 Co-Authors
Mohamed Abdel-Hamid
G Thomas Strickland
Gamal Shiha
Doaa A Saleh
Alan D Fix
Mostafa K Mohamed
Sonia K Stoszek
Soraya Sharaf
Reham Soliman
Fatma Abdel-Aziz
Published In
Trans R Soc Trop Med Hyg
J Egypt Soc Parasitol
Am J Trop Med Hyg
J Hepatol
Clin Res Hepatol Gastroenterol
Affiliations
Soon will be listed here.
Recent Articles
1.
Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective study
Shiha G, Hassan A, Mousa N, El-Domiaty N, Mikhail N, Gameaa R, et al.
Aliment Pharmacol Ther . 2024 Sep; 61(1):99-108. PMID: 39313490
Background: Several HCC risk stratification scores were developed; however, none has been prospectively validated. The primary aim is to validate the clinical utility of six HCC risk scores in large...
2.
Management of patients with CHB outside the guidelines: Insights from Egyptian cohort with long-term follow-up
Shiha G, Soliman R, Hassan A, Farahat A, Salem A, Taha A, et al.
Clin Liver Dis (Hoboken) . 2024 Jun; 23(1):e0183. PMID: 38881725
It is alarming that globally, only 2.2% (6.6 million) of patients with chronic hepatitis B (CHB) received treatment in 2019. One contributing factor to this low treatment rate is the...
3.
Validation of SMART model for HCC risk stratification in genotype -4 HCV patients following SVR and its comparison with GES score
Shiha G, Mikhail N, Soliman R
J Hepatol . 2024 May; 81(5):e223-e225. PMID: 38759890
No abstract available.
4.
Letter: comparison of clinical prediction rules for ruling out cirrhosis in non-alcoholic fatty liver disease (NAFLD)
Shiha G, Mikhail N, Soliman R
Aliment Pharmacol Ther . 2022 Aug; 56(6):1098-1099. PMID: 35995744
No abstract available.
5.
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
Azzi J, Dorival C, Cagnot C, Fontaine H, Lusivika-Nzinga C, Leroy V, et al.
Clin Res Hepatol Gastroenterol . 2022 Apr; 46(6):101923. PMID: 35405354
Background & Aims: Prediction of hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C (HCV) who achieved a sustained virological response (SVR) after direct acting antivirals (DAAs) remains challenging....
6.
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation score
Shiha G, Soliman R, Mikhail N, Hassan A, Eslam M
Liver Int . 2021 Jun; 41(11):2768-2776. PMID: 34174150
Background And Aims: With the growing number of treated hepatitis C patients, the current 'one-size-fits-all' hepatocellular carcinoma (HCC) surveillance strategies for patients with advanced fibrosis represents a great burden on...
7.
HCC developed in CHC patients who achieved SVR following DAAs tend to display less aggressive pattern
Shiha G, Soliman R, Mikhail N, Zaky S
Clin Res Hepatol Gastroenterol . 2021 Jan; 45(3):101608. PMID: 33414059
No abstract available.
8.
External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs
Shiha G, Mikhail N, Soliman R
J Hepatol . 2020 Dec; 74(4):994-996. PMID: 33340577
No abstract available.
9.
Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-centre cohort of European cirrhotics
Shiha G, Soliman R, Mikhail N, Eslam M
Liver Int . 2020 Nov; 41(5):1155-1156. PMID: 33155346
No abstract available.
10.
Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response
Abdelwahab S, Zakaria Z, Sobhy M, Hamdy S, Mahmoud M, Mikhail N, et al.
Arch Virol . 2015 May; 160(7):1741-50. PMID: 25971683
The CC genotype of the interleukin (IL)-28B.rs12979860 gene has been associated with spontaneous hepatitis C virus (HCV) clearance and treatment response. The distribution and correlation of an IL28B.rs12979860 single-nucleotide polymorphism...